MediFind
Condition

Non-Alcoholic Fatty Liver Disease

Latest Research

Latest Advance
Study
  • Condition: Older Women with Non-Alcoholic Fatty Liver Disease
  • Journal: Journal of bodywork and movement therapies
  • Treatment Used: Non-Linear Resistance Training and Curcumin Supplementation
  • Number of Patients: 45
  • Published —
This study examined the effects of nonlinear resistance training and curcumin supplementation in obese older women with non-alcoholic fatty liver disease.
Latest Advance
Study
  • Condition: Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Journal: International journal of molecular sciences
  • Treatment Used: Probiotics, Prebiotics, Synbiotics, Fecal Microbiome Transplantation, and Fasting-Mimicking Diet
  • Number of Patients: 0
  • Published —
This article summarized the roles of various bacterial metabolites in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and their therapeutic implications.
Latest Advance
Study
  • Condition: Liver Diseases
  • Journal: International journal of molecular sciences
  • Treatment Used: Adiponectin
  • Number of Patients: 0
  • Published —
The study researched the uses of Adiponectin between 2010 - 2020.
Latest Advance
Study
  • Condition: Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Type 2 Diabetes
  • Journal: Nutrients
  • Treatment Used: Eating Slowly
  • Number of Patients: 308
  • Published —
This study evaluated eating speed in men and women with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM).
Latest Advance
Study
  • Condition: Premenopausal Breast Cancer
  • Journal: BMC cancer
  • Treatment Used: Toremifene (TOR) vs. Tamoxifen (TAM)
  • Number of Patients: 92
  • Published —
This study compared the safety of toremifene (TOR) versus tamoxifen (TAM) in the adjuvant treatment of pre-menopausal patients with breast cancer.
Latest Advance
Study
  • Condition: Deferasirox-Induced Liver Injury and Fanconi Syndrome in Male Patient with Beta-Thalassemia Major
  • Journal: BMJ case reports
  • Treatment Used: Cessation of Deferasirox
  • Number of Patients: 1
  • Published —
This case report discusses a Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male patient.
Latest Advance
Study
  • Condition: Obesity and Metabolic Disorders
  • Journal: United European gastroenterology journal
  • Treatment Used: Endoscopic Bariatric and Metabolic Therapies (EBMTs)
  • Number of Patients: 0
  • Published —
This article discusses the current evidence on endoscopic bariatric (weight loss) and metabolic therapies (EBMTs) in the treatment of obesity and metabolic disorders.
Latest Advance
Study
  • Condition: COVID-19
  • Journal: Cell metabolism
  • Treatment Used: Statins
  • Number of Patients: 13981
  • Published —
In this study, researchers evaluated the outcomes of taking statins while being treated for COVID-19.
Latest Advance
Study
  • Condition: Chronic Viral Hepatitis C
  • Journal: Scientific reports
  • Treatment Used: Interferon-Free Treatment
  • Number of Patients: 20
  • Published —
This study tested the safety and efficacy of using interferon-free treatment to treat patients with chronic viral hepatitis C infections.
Latest Advance
Study
  • Condition: Advanced Hepatocellular Carcinoma (HCC) with Cirrhosis or Nonalcoholic Steatohepatitis or Liver Metastases
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: MTL-CEBPA
  • Number of Patients: 38
  • Published —
This study considered patients with advanced hepatocellular carcinoma (advanced liver cancer; HCC) who also have cirrhosis or nonalcoholic steatohepatitis (buildup of fat in the liver) or liver metastases (tumors in the liver) in order to analyze the safety and effectiveness of MTL-CEBPA.
Latest Advance
Study
  • Condition: Diabetes with Chronic Hepatitis B
  • Journal: Journal of viral hepatitis
  • Treatment Used: Thiazolidinediones
  • Number of Patients: 28999
  • Published —
The study researched the outcomes of Thiazolidinediones in patients with diabetes with chronic hepatitis B.